---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-025492"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2021-10-15T23:59:59+00:00"
generated_at: "2026-06-28T20:31:01.366507+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics prices $7.9M public offering, uplists to Nasdaq, effects 1-for-2.5 reverse split

## Summary
- Offering of 1,510,455 units at $5.25/unit raised $7.9M gross; units consist of 1 share + 1 warrant (strike $6.30, 5-year term).
- Common stock and warrants began trading on Nasdaq Capital Market Oct 13 under symbols BBLG and BBLGW.
- Company effected 1-for-2.5 reverse stock split effective Oct 12, 2021.
- Underwriters granted 45-day over-allotment option for up to 226,568 additional shares and/or warrants.
- WallachBeth Capital acted as sole book-running manager; closing expected Oct 15, 2021.

## SEC filing metadata
- accession: 0001493152-21-025492
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2021-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315221025492/0001493152-21-025492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315221025492/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-025492
- JSON: https://secwatch.observer/filing/0001493152-21-025492.json
- Plain text: https://secwatch.observer/filing/0001493152-21-025492.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.